Key opportunities in the clinical trial platform market include leveraging AI and machine learning for enhanced trial design ...
Humain, the Saudi Arabia-based artificial intelligence company backed by the Public Investment Fund, has launched Humain One, ...
The move is backed by investors including Kraken and Fabric Ventures, and OceanPal's shipping business will continue to operate separately.